Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAntisense Therapeutics Ltd.

Antisense Therapeutics Ltd.

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2024-04-09T03:52:55.142304Z
Market Cap
0.00M

Momentum Score

…

Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase IIa clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.05
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.01
ROE
-
Net Debt
-10.83M
ROCE
-133.04%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -11.38M -5.81M -8.06M -5.91M -2.94M
Net income -11.38M -5.83M -8.07M -5.89M -2.31M
Selling general administrative 3.05M 2.92M 3.56M 4.46M 1.68M
Gross profit - - - - 0.45M
Reconciled depreciation 0.10M 0.09M 0.10M 0.11M 0.01M
Ebit -13.34M -7.61M -8.68M -6.67M -3.58M
Ebitda -13.25M -7.52M -8.58M -6.56M -3.58M
Depreciation and amortization 0.10M 0.09M 0.10M 0.11M 0.01M
Operating income -13.34M -7.61M -8.68M -6.67M -3.58M
Other operating expenses 13.34M 7.61M 8.68M 6.67M 3.58M
Interest expense - 0.02M 0.00M 0.00M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.38M 0.03M 0.00M 0.01M 0.01M
Net interest income 0.38M 0.02M -0.01M -0.01M 0.07M
Income tax expense -0.38M 0.02M 0.01M -0.02M -0.64M
Total revenue 0.38M 0.03M 0.00M 0.03M 0.07M
Total operating expenses 13.34M 7.61M 8.68M 6.67M 3.58M
Cost of revenue - - - - 0.14M
Total other income expense net 1.59M 1.80M 0.62M 0.76M 0.64M
Net income from continuing ops -11.38M -5.81M -8.06M -5.91M -2.94M
Net income applicable to common shares -11.38M -5.81M -8.06M -5.91M -2.94M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 12.84M 22.44M 7.00M 5.35M 3.70M
Other current assets 1.47M 0.53M 0.67M 0.26M 0.26M
Total liab 2.87M 1.30M 1.27M 0.82M 0.89M
Total stockholder equity 9.98M 21.14M 5.73M 4.53M 2.81M
Other current liab 1.79M 0.83M 0.89M 0.69M 0.65M
Common stock 98.26M 98.13M 77.03M 69.15M 63.94M
Capital stock 98.26M 98.13M 77.03M 69.15M 63.94M
Retained earnings -92.29M -80.91M -75.10M -67.04M -61.13M
Other liab 0.01M 0.00M 0.00M - 0.01M
Cash 10.97M 19.23M 6.02M 4.06M 2.90M
Cash and equivalents - - 6.02M 4.06M 2.90M
Total current liabilities 2.81M 1.16M 1.05M 0.80M 0.88M
Current deferred revenue -0.09M -0.09M -0.08M -0.11M -0.11M
Net debt -10.83M -19.01M -5.71M -3.92M -2.77M
Short term debt 0.09M 0.09M 0.08M 0.11M 0.11M
Short long term debt total 0.14M 0.23M 0.31M 0.14M 0.14M
Other stockholder equity 4.00M 3.92M 3.79M 2.72M -2.42M
Property plant equipment 0.15M 0.22M 0.30M 0.14M 0.00M
Total current assets 12.69M 22.22M 6.70M 5.21M 3.70M
Net tangible assets 9.98M 21.14M 5.73M 4.53M 2.81M
Short term investments 10.50M 18.42M - - -
Net receivables 1.66M 1.84M 0.60M 0.69M 0.61M
Inventory 0.00M 0.00M 0.00M 0.21M -0.07M
Accounts payable 1.02M 0.33M 0.16M 0.11M 0.23M
Accumulated other comprehensive income 4.00M 3.92M 3.79M 2.42M 2.42M
Common stock total equity - - - 69.15M 63.94M
Non currrent assets other -0.15M -0.22M -0.30M -0.14M 0.00M
Non current assets total 0.15M 0.22M 0.30M 0.14M 0.00M
Capital lease obligations 0.14M 0.23M 0.31M 0.14M -
Long term debt total 0.05M 0.13M 0.23M 0.02M 0.00M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.03M -0.00M -0.01M -0.01M 2.40M
Change to liabilities 1.76M 0.03M 0.22M -0.26M 0.22M
Total cashflows from investing activities -0.03M -0.00M -0.01M -0.01M 2.40M
Net borrowings -0.09M -0.08M -0.08M -0.10M -0.10M
Total cash from financing activities -0.09M 21.02M 7.80M 5.11M 1.53M
Change to operating activities 0.77M -1.00M 0.45M 0.03M 0.07M
Net income -11.38M -5.81M -8.06M -5.91M -2.94M
Change in cash -8.27M 13.21M 1.96M 1.16M 1.00M
Begin period cash flow 19.23M 6.02M 4.06M 2.90M 1.90M
End period cash flow 10.97M 19.23M 6.02M 4.06M 2.90M
Total cash from operating activities -8.15M -7.81M -5.83M -3.95M -2.93M
Issuance of capital stock - 22.59M 8.50M 5.49M 1.60M
Depreciation 0.10M 0.09M 0.10M 0.11M 0.01M
Other cashflows from investing activities - - - 0.00M 2.40M
Dividends paid - 0.08M 0.08M 0.10M -
Change to account receivables 0.34M -1.24M 0.09M -0.34M -0.28M
Sale purchase of stock 0.00M -1.49M -0.61M -0.29M -0.07M
Other cashflows from financing activities -0.03M 0.08M 0.08M 0.10M 2.40M
Change to netincome 0.26M 0.12M 1.37M 2.42M 2.42M
Capital expenditures 0.03M 0.00M 0.01M 0.01M 0.01M
Change in working capital 0.34M -1.24M 0.09M -0.34M 0.36M
Stock based compensation 0.21M 0.12M 1.37M 2.42M -
Other non cash items 3.13M -2.08M 2.12M 1.86M 2.94M
Free cash flow -8.18M -7.81M -5.84M -3.96M -0.01M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
AFP
Aft Pharmaceuticals Ltd		 0.05
1.41%		 3.60 29.92 18.18 1.48 4.37
VLS
Vita Life Sciences Ltd		 0.09
3.42%		 2.72 13.50 42.73 1.52 2.62
LGP
Little Green Pharma Ltd		 0.01
16.67%		 0.07 - 10.00 0.64 0.60
MVP
Medical Developments International Ltd		 -
-%		 0.44 40.00 166.67 1.06 0.79

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…